ID: ALA4565874

Max Phase: Preclinical

Molecular Formula: C35H49NO10

Molecular Weight: 643.77

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CO[C@@H](/C(C)=C/C=C/C(C)=C/c1coc(C)n1)[C@@H](C)[C@@H]1C[C@H](O)[C@@](C)(O)/C=C/[C@H](O)[C@@H](C)[C@H]2C[C@H](CC(=O)O2)C[C@@H]2O[C@H]2C(=O)O1

Standard InChI:  InChI=1S/C35H49NO10/c1-19(13-25-18-43-23(5)36-25)9-8-10-20(2)32(42-7)22(4)28-17-30(38)35(6,41)12-11-26(37)21(3)27-14-24(16-31(39)44-27)15-29-33(45-29)34(40)46-28/h8-13,18,21-22,24,26-30,32-33,37-38,41H,14-17H2,1-7H3/b9-8+,12-11+,19-13+,20-10+/t21-,22+,24+,26+,27-,28+,29+,30+,32+,33-,35+/m1/s1

Standard InChI Key:  MGMHBFBKYBCOPO-RKNMXKMUSA-N

Associated Targets(Human)

TC-32 111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A673 619 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-ES1 32 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hep293TT 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 643.77Molecular Weight (Monoisotopic): 643.3356AlogP: 4.00#Rotatable Bonds: 7
Polar Surface Area: 161.08Molecular Species: NEUTRALHBA: 11HBD: 3
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.42CX Basic pKa: 0.58CX LogP: 2.45CX LogD: 2.45
Aromatic Rings: 1Heavy Atoms: 46QED Weighted: 0.17Np Likeness Score: 2.36

References

1. Carter AC, Petersen CL, Wendt KL, Helff SK, Risinger AL, Mooberry SL, Cichewicz RH..  (2019)  In Situ Ring Contraction and Transformation of the Rhizoxin Macrocycle through an Abiotic Pathway.,  82  (4): [PMID:30865445] [10.1021/acs.jnatprod.8b00974]

Source